UnitedHealthcare Cuts Prior Authorization Requirements by 30% rewrite title UnitedHealthcare is eliminating authorization requirements for 30% of healthcare services that previously required insurer approval. This initiative builds on a series…
New research reveals distinct cellular pathways behind fetal anemia, paving the way for more precise and personalized therapies A new scientific study has shed light on one of the most…
Omnicell, Inc. to Present at BofA Securities 2026 Healthcare Conference Omnicell, a prominent player in the healthcare technology sector known for its focus on advancing autonomous medication management, has announced…
Travere Therapeutics Announces Q1 2026 Financial Results Travere Therapeutics, Inc. reported a strong start to 2026, marked by significant commercial growth, regulatory milestones, and continued advancement across its pipeline programs.…
Mettler-Toledo International Inc. to Present at BofA Securities 2026 Healthcare Conference Mettler-Toledo International, a global leader in precision instruments and services, has announced its participation in the BofA Securities 2026…
ODAC Endorses TRUQAP Combination Therapy Based on Phase III CAPItello-281 Results Showing Improved Progression-Free Survival and Addressing Unmet Need The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC)…
Cairn Surgical, Inc. Announces Pivotal Trial Success for Breast Cancer Locator System, Demonstrating Improved Surgical Outcomes Cairn Surgical, Inc., a medical technology innovator focused on improving precision in breast cancer…
RestorixHealth and Industry Leaders Highlight the Legacy, Innovation, and Healing Power of Hyperbaric Medicine In the evolving landscape of modern healthcare, few therapies demonstrate the blend of historical significance and…
Strategic partnership launches CIO Leadership Exchange to empower IT leaders with AI, data, and digital transformation expertise across community health centers nationwide The National Association of Community Health Centers (NACHC)…
BeOne Medicines Gains FDA Priority Review for TEVIMBRA in First-Line HER2+ Gastroesophageal Adenocarcinoma BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, has announced a major regulatory milestone in the development…
Strand Therapeutics Advances In Vivo CAR-T Therapy with Programmable circRNA Platform Strand Therapeutics, a clinical-stage biotechnology company at the forefront of programmable RNA medicines, has announced the presentation of compelling…
Motif Neurotech Secures FDA Approval for First Clinical Trial of Depression-Focused BCI Motif Neurotech, a pioneering brain-computer interface company focused on mental health innovation, has reached a major milestone with…